TL;DR: A 2026 systematic review and meta-analysis in Pain Medicine found that Medicaid enrollment and preoperative benzodiazepine use had the largest pooled associations with new persistent opioid use after surgery among opioid-naive US adults. Key Findings 27 cohort studies: The review included US adult surgical studies that separated opioid-naive patients from those using opioids before …
TL;DR: A 2026 protocol in JMIR Research Protocols describes EXCEL-PD, a randomized trial testing whether 26 weeks of virtually supervised home endurance and resistance exercise is feasible, safe, and biologically informative for people with Parkinson disease. Key Findings Home trial design: EXCEL-PD randomizes 31 planned participants with Parkinson disease to home-based exercise or waitlist usual …
TL;DR: A 2026 secondary analysis in Drug and Alcohol Dependence found 4 cannabis craving trajectories during treatment, with the high-craving group showing more positive urine cannabinoid tests and higher baseline anxiety, depression, and obsessive-compulsive cannabis-use symptoms. Key Findings Trial reanalysis: Researchers reanalyzed a 12-week multisite cannabis use disorder trial of 302 adults assigned to N-acetylcysteine …
TL;DR: A 2026 study in Neuropsychopharmacology found that 30 mg 2C-B produced acute subjective effects in healthy adults that were similar in overall intensity to 125 mg MDMA, shorter and less distressing than 25 mg psilocybin, and less cardiovascularly stimulating than MDMA. Key Findings Crossover comparison: The double-blind study tested 10, 20, and 30 mg …
TL;DR: A 2026 study in Nature Communications found that proteotoxic stress can push neurons into karyoptosis, a cell-death pathway marked by nuclear lamina breakdown, nuclear-material expulsion, and dementia-linked tissue signatures. Key Findings Karyoptosis was induced by protein-clearance stress: Blocking autophagic lysosomal clearance caused LaminB1 disruption, nuclear-shape loss, cytoplasmic nuclear material, and later cell death. p38-LaminB1 …
TL;DR: A 2026 ADNI analysis posted to medRxiv found that brain-derived plasma pTau217 better predicted near-term amyloid positron emission tomography (PET) positivity than total plasma pTau217 in cognitively unimpaired amyloid-negative participants. Key Findings 1,427 ADNI participants: Plasma NULISAseq biomarkers were measured across the broader Alzheimer’s Disease Neuroimaging Initiative sample. 529 cognitively unimpaired: The main prognostic …
TL;DR: A 2026 retrospective analysis posted to medRxiv linked diclofenac and naproxen use in the NACC cohort to lower dementia and Alzheimer disease prevalence, while diclofenac use was also associated with slower Montreal Cognitive Assessment (MoCA) cognitive-screening decline. Key Findings NACC cohort: The analysis used 47,165 National Alzheimer’s Coordinating Center participants with data collected from …
TL;DR: A 2026 medRxiv preprint reported that peripheral blood RNA sequencing separated Parkinson disease from healthy controls and isolated REM sleep behavior disorder more clearly than it separated isolated REM sleep behavior disorder from controls. Key Findings 71 baseline samples: The main analysis included 20 healthy controls, 31 people with isolated REM sleep behavior disorder, …
TL;DR: A 2026 protocol posted to medRxiv describes a nationwide Japan survey designed to measure how dementia specialists handle anti-amyloid antibody therapy, biomarker testing, MRI safety monitoring, service capacity, and patient-choice tradeoffs. Key Findings Nationwide specialist survey: The protocol targets board-certified dementia specialists in Japan, especially physicians trained for anti-amyloid antibody therapy. June 2026 data …
TL;DR: A 2026 randomized trial posted to medRxiv found that connectivity-guided accelerated intermittent theta-burst stimulation added to inpatient care improved treatment-resistant depression scores more than sham stimulation over 2 weeks. Key Findings 57 randomized patients: Hospitalized adults with unipolar treatment-resistant depression were assigned to active or sham stimulation. 30 iTBS sessions: Active treatment delivered 3 …
